Jun 17, 2020
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B
Jun 08, 2020
Prime Therapeutics and EMD Serono ink value-based agreement on MAVENCLAD® (cladribine) tablets
May 15, 2020
Can-Fite Announces Pre-IND Submission to U.S. FDA for Piclidenoson in the Treatment of COVID-19 Infected Patients with Moderate-to-Severe Symptoms
Aug 12, 2019
A New Class of Kinase Inhibitors for the Treatment of Cardiovascular Disease
Aug 08, 2019
GameOn, Set, Match: ATP Media Partners with Content Engagement Platform GameOn to Serve Tennis Fans All the Action in Chat
Jul 12, 2019
Zydelig (idelalisib; Gilead) Drug Overview 2019: An Oral, Highly Selective Inhibitor of the Phosphoinositide 3-Kinase (PI3K) Isoform p110-delta
Jun 12, 2019
KIPPO Science Launches Global Regenerative Medicine "ATP" Website
May 02, 2019
Genital Herpes Treatment Drugs: Global Market Insights & Projections, 2016 to 2026
Apr 08, 2019
MAVENCLAD® (Cladribine) Tablets Now Covered by Express Scripts
Mar 29, 2019
FDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis
Mar 06, 2019
Inosine (CAS 58-63-9): Global Market Research Report, 2019 - ResearchAndMarkets.com
Feb 28, 2019
EMD Serono to Present Multiple Sclerosis Data on Cladribine Tablets and Evobrutinib at ACTRIMS 2019
Feb 14, 2019
Genital Herpes Market Insights, Epidemiology and Market Forecasts Report 2019 Featuring Novartis, GlaxoSmithKline, Genocea Biosciences, AiCuris & Maruho
Feb 11, 2019
NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm
Feb 06, 2019
Biotechnology Companies See Growth in Optic Treatment Sectors
Feb 04, 2019
Cytomegalovirus Treatment Market Expected to Behold a CAGR of 6% Through 2018 - 2028
Feb 04, 2019
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
Jan 30, 2019
ADP Reports Second Quarter Fiscal 2019 Results
Oct 16, 2018
Catalent and Verastem Oncology Partner on Newly Launched, FDA Approved COPIKTRA(TM) (duvelisib) Capsules
Oct 10, 2018
Up to 10-Years of Follow-up Data Reaffirm Safety Profile of Investigational Cladribine Tablets